Chlorhexidine dressing care for port and central catheters in children
Part of Cancer clinical trials.
This trial tests whether a special care bundle with a germ-killing dressing can reduce infections in children with port or central line catheters. It may help keep your child safer during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 and 17 years old
- Your child is currently in the hospital (for more than 48 hours) getting treatment for blood cancer, other cancer, or a stem cell transplant
- Your child has a port catheter placed without early problems
- You and your child agree to join the study and sign a consent form
- Your child does not have an infection throughout their body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a liquid that is put into the dialysis catheter after each session to prevent infections that can happen through the catheter. It is designed for children up to age 18 who need hemodialysis through a catheter.
This study tests whether putting a small cap containing chlorhexidine (a germ-killing medicine) on the end of the dialysis catheter can prevent serious bloodstream infections. If you are on dialysis with a catheter, this may help reduce your risk of infection.
This trial teaches nurses how to better care for a port-a-catheter (a small device placed under the skin to give chemotherapy). It looks at whether special training helps nurses improve their skills. If you are a nurse with at least one year of experience in an oncology unit, this might be for you.
This trial tests whether giving a blood thinner before placing a central line (a special IV) helps prevent clots in critically ill children. It could lower the risk of problems from the line.
This trial studies skin reactions caused by dressings used on chest implantable ports (small devices under the skin to deliver chemo). It is for adults starting their first chemo, who have a chest port.
This trial studies how often PICC line dressings are changed in people with acute myeloid leukemia who are getting intensive chemotherapy and are at high risk for serious infection. The goal is to see whether changing dressings more or less often affects infection risk or other outcomes.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.